Possibilities and Benefits of International Collaboration for Innovative Companies Martin Wassell Managing Director European Institutes
Agenda What is an Innovative Company? Why Collaborate …. Internationally Barriers to Innovation Benefits of International Collaboration for Innovation Framework Programme 7 Eurostars Case Studies Questions
Agenda What is an Innovative Company? Why Collaborate …. Internationally Barriers to Innovation Benefits of International Collaboration for Innovation Framework Programme 7 Eurostars Case Studies Questions
What is an Innovative Company? Value Chain Process Innovation Product 3 Innovation Business Model Innovation 2 4 Innovation Structural Innovation Application Revenue Growth Innovation Frontier Research Main Street (Mature) Early Market Time Death Valley Bowling Tornado Alley 1 Main Street (Early) Main Street (Declining) Indefinitely Elastic Middle Period Young Innovative Company (YIC) – less than 15 years old and spend at least 15% of expenditures on R&D Fault Line End Of Life
Agenda What is an Innovative Company? Why Collaborate …. Internationally Barriers to Innovation Benefits of International Collaboration for Innovation Framework Programme 7 Eurostars Case Studies Questions
Why Collaborate …. . Internationally? Innovation Barriers International Benefits? Select the best opportunity International expertise for concept and balance risk/reward? Development and market compliance Access the best suppliers, International markets through distributors and customers? large customers, best suppliers and dist. Develop product, process Best in class R&D and technology and service solutions? development Scale up to access markets Customer, supplier and distribution National and International? Networks for rapid market access Maximise product Extended product, process or service lifespan and profit? market acceptance and penetration
Agenda What is an Innovative Company? Why Collaborate …. Internationally Barriers to Innovation Benefits of International Collaboration for Innovation Framework Programme 7 Eurostars Case Studies Questions
FP 7 An Opportunity for Collaboration Ideas € 7, 460 Cooperation € 32, 365 People € 4, 728 JRC € 1, 751 Capacities € 4, 217 Euratom € 2, 751 1. 2. 3. € 1. 4 Bn Thematically unrestricted 100% cost reimbursed Excellent cash flow
Open Innovation …and the Smart Use of Public Funding
How This Programme Supports International Collaboration The DNA of Successful International Business Development 1 2 Developing the 95% of Costs Value of New Paid for by the Ideas EC 3 4 5 6 Access to World Class R&D Resources Creation of Full Value Chain International Distribution Network Develop Key Customer Relationships
How This Programme Supports International Collaboration The DNA of Successful International Business Development 1 2 Developing the 95% of Costs Value of New Paid for by the Ideas EC 3 4 5 6 Access to World Class R&D Resources Creation of Full Value Chain International Distribution Network Develop Key Customer Relationships
Developing The Value of New Ideas! Customers Competences
Developing The Value of New Ideas! Quality Performance Cost Flexibility Delivery Functionality EC funding is about creating sales, wealth …and high value jobs! Customer Relationship
How This Programme Supports International Collaboration The DNA of Successful International Business Development 1 2 Developing the 95% of Costs Value of New Paid for by the Ideas EC 3 4 5 6 Access to World Class R&D Resources Creation of Full Value Chain International Distribution Network Develop Key Customer Relationships
The Value Proposition Develop the value & differentiation of new offering ideas Provide access to experts to outsource/co-deliver the R&D Develop your idea into a commercially validated prototype Build new technical capabilities into your value chain Develop new market access & customer relationships Create 95% cost leverage for you with no dilution of IPR & equity
Cost Leverage Potential When You Carry Out Part of the R&D Smart Use of Public funding
Total Project € 3, 500 k costs € 2, 500 k grant 71 % reimbursed € 500 k costs € 375 k grant 75% reimbursed R&D Partner 1 € 500 k costs € 375 k grant 75% reimbursed University R&D Partner 6 R&D Partner 2 SME € 500 k costs € 375 k grant 75% reimbursed You R&D Partner 5 R&D Partner 3 Research Inst SME R&D Partner 4 € 500 k costs € 375 k grant 75% reimbursed Large Firm € 500 k costs € 250 k grant 50% reimbursed € 500 k costs € 375 k grant 75% reimbursed
Total Project Effort Secured € 3, 500 k R&D Partner 1 University R&D Partner 6 R&D Partner 2 SME You R&D Partner 5 R&D Partner 3 Research Inst SME R&D Partner 4 Large Firm € 155 k of your costs, leverage € 3, 500 k of R&D creating IPR for you at 95% leverage
Cost Leverage Potential When You Outsource the R&D Smart Use of Public funding
Total Project € 1, 500 k costs € 1, 125 k grant 75 % reimbursed € 1, 125 k grant pays R&D service provider costs Supply Partner 1 SME Distributor Partner 6 Supply Partner 2 SME R&D Performer 1 SME Research Inst You Distributor Partner 5 Supply Partner 3 SME Customer Partner 4 Large Firm € 375 kof SME costs 7 ways € 53 k each Split R&D Performer 1 Research Inst
Total Project Effort Secured € 3, 500 k R&D Partner 1 University R&D Partner 6 R&D Partner 2 SME R&D Performer 1 Research Inst SME You R&D Partner 5 R&D Partner 3 Research Inst SME R&D Partner 4 Large Firm € 80 k of your costs, leverage € 1, 500 k of R&D creating IPR for you at 95% leverage R&D Performer 1 Research Inst
The Experts Available Through the Programme Route to Market Co-Investment EC Expertise Control of IPR
No Cranks or Tyre Kickers!
Agenda What is an Innovative Company? Why Collaborate …. Internationally Barriers to Innovation Benefits of International Collaboration for Innovation Framework Programme 7 Eurostars Case Studies Questions
Eurostars A Eurostars project European research and development project Address any technological area • development of a new product, process or service Collaborative – minimum of 2 participants from 2 different Eurostars participating countries Main participant must be a research-performing SME from one of these countries Project should be market-driven with a maximum duration of 3 years Within 2 years of project completion • product of the research should be ready for launch onto the market (except biomedical or medical projects, where clinical trials must be started within two years of project completion) First deadline – 8 th February 2008
Agenda What is an Innovative Company? Why Collaborate …. Internationally Barriers to Innovation Benefits of International Collaboration for Innovation Framework Programme 7 Eurostars Case Studies Questions
Improved Functionality Enables Pain Relief Eluted drug Fibro id Polyvinyl Beads Uterine artery “With this new alternative to invasive surgery, we see our market growing to over € 100 m. A key element of success was the access to R&D skills that we don’t have internally. ” Andrew Lewis, Technical Director, Biocompatibles Ltd
Improved Product Function Improves Patient Outcome The project allowed us to investigate novel surface features to allow earlier product fixation resulting in the potential for implant longevity. Alan Taylor CEO, Finsbury Ltd
Decision Support Software Improves Flexibility For Orthopaedic Implants This technology represents a major part of our product development programme for the next 10 years Allen Ritchie VP R&D De. Puy plc,
Agenda What is an Innovative Company? Why Collaborate …. Internationally Barriers to Innovation Benefits of International Collaboration for Innovation Framework Programme 7 Eurostars Case Studies Questions
Thank You
Скачать презентацию Possibilities and Benefits of International Collaboration for Innovative
e4e84422baa36798891d15d40d9504f5.ppt